NCT00588393View on ClinicalTrials.gov

FolateScan in Autoimmune Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Rheumatoid ArthritisOsteoarthritisMultiple SclerosisCrohn's DiseaseSystemic Lupus Erythematosus
Interventions
DRUG

FolateScan (Technetium Tc 99mEC20)

0.1 mg. of EC20 labeled with 20-25 mCi of technetium-99m followed by FolateScan

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Endocyte
All Listed Sponsors
collaborator

Endocyte

INDUSTRY

lead

Mayo Clinic

OTHER